Published in Angiogenesis Weekly, September 6th, 1999
Angiogenesis studies on vascular endothelial growth factor (VEGF) - also known as vascular permeability factor (VPF) - address various types of malignant tumors; however, little is known about the role or significance of VEGF in human thyroid neoplasms, noted R. Katoh and colleagues at Japan's Yamanashi Medical University School of Medicine.
Therefore, Katoh et al. performed a study to determine whether VEGF is found in normal and neoplastic thyroids and whether its...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Angiogenesis Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.